CVE-2023-32261

Dimensions CM Plugin for Jenkins 0.8.17 – 0.9.3

Description

A potential vulnerability has been identified in the Micro Focus Dimensions CM Plugin for Jenkins. The vulnerability allows attackers with Overall/Read permission to enumerate credentials IDs of credentials stored in Jenkins. See the following Jenkins security advisory for details: * https://www.jenkins.io/security/advisory/2023-06-14/ https://www.jenkins.io/security/advisory/2023-06-14/

Remediation

Solution:

  • Micro Focus has resolved the vulnerability in the latest release of the Dimensions CM Plugin for Jenkins (version 0.9.3.1): https://plugins.jenkins.io/dimensionsscm/ https://plugins.jenkins.io/dimensionsscm/

Category

4.2
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.26%
Vendor Advisory microfocus.com
Affected: Micro Focus Dimensions CM
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-32261?
CVE-2023-32261 has been scored as a medium severity vulnerability.
How to fix CVE-2023-32261?
To fix CVE-2023-32261: Micro Focus has resolved the vulnerability in the latest release of the Dimensions CM Plugin for Jenkins (version 0.9.3.1): https://plugins.jenkins.io/dimensionsscm/ https://plugins.jenkins.io/dimensionsscm/
Is CVE-2023-32261 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-32261 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-32261?
CVE-2023-32261 affects Micro Focus Dimensions CM.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.